How a Director’s Stock Sale and MMAE Optimism At Penumbra (PEN) Has Changed Its Investment Story

On January 6, 2026, a Penumbra director reported selling 186 shares, while a recent analyst report highlighted growing ...

Assessing Penumbra (PEN) Valuation After Analyst Optimism And Strong Third Quarter Guidance

What triggered fresh attention on Penumbra Recent analyst optimism around Penumbra (PEN), centered on its middle meningeal ...
Seeking Alpha

Johnson & Johnson Receives FDA Approval for TRUFILL n‑BCA Liquid Embolic System for the Treatment of Symptomatic Chronic Subdural Hematoma

- TRUFILL n-BCA is now indicated for embolization of the middle meningeal artery (MMA) for the treatment of symptomatic subacute and Chronic Subdural Hematoma (cSDH) as an adjunct to surgery. - ...
The New England Journal of Medicine

Embolization for Chronic Subdural Hematoma

Among patients receiving surgical or nonsurgical standard treatment for chronic subdural hematoma, adjunctive middle meningeal artery embolization reduced the risk of treatment failure within 180 days ...